Sector revisions Bayer AG

Equities

Market Closed - Xetra Other stock markets 16:35:01 17/06/2025 BST			Pre-market 06:57:50
27.16 ^EUR	-1.50%		26.98	-0.68%

06-17	Bayer Files for FDA Approval of Gadoquatrane	DJ
06-17	Bayer Seeks US FDA Nod for MRI Contrast Agent Gadoquatrane	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility (Composite)	Nbr of analysts
	BAYER AG							20
	ELI LILLY AND COMPANY							27
	JOHNSON & JOHNSON							23
	NOVO NORDISK A/S							22
	ABBVIE INC.							27
	ROCHE HOLDING AG							20
	NOVARTIS AG							19
	ASTRAZENECA PLC							20
	MERCK & CO., INC.							24
	AMGEN INC.							28
	PFIZER, INC.							23
	GILEAD SCIENCES, INC.							26
	SANOFI							23
	VERTEX PHARMACEUTICALS INCORPORATED							28
	BRISTOL-MYERS SQUIBB COMPANY							22
	CHUGAI PHARMACEUTICAL CO., LTD.							14
	GSK PLC							19
	JIANGSU HENGRUI MEDICINE CO., LTD.							16
	HALEON PLC							17
	Average							22
	Weighted average by Cap.							23